UCG-LYPHOTEST

UCG-LYPHOTEST is an FDA 510(k)-cleared medical device (K791309) manufactured by Wampole Laboratories. This device is classified under the Clinical Chemistry specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on July 29, 1979. Regulation: 8.